Jeong-Woong Park1, Kyoung Hwan Kim2, Sujung Kim3, Jae-Rung So4, Byung-Wook Cho2, Ki-Duk Song3,5. 1. Department of Animal Science and Biotechnology, Kyungpook National University, SangJu 37224, Korea. 2. Department of Animal Science, College of Natural Resources and Life Sciences, Pusan National University, Miryang 50463, Korea. 3. The Animal Molecular Genetics and Breeding Center, Jeonbuk National University, Jeonju 54896, Korea. 4. Department of Animal Science, Jeonbuk National University, Jeonju 54896, Korea. 5. Department of Agricultural Convergence Technology, Jeonbuk National University, Jeonju 54896, Korea.
The performance of racing horses is primarily related to their energy metabolism, and
numerous enzymes and metabolites are involved in this process [1]. The total muscle blood flow, oxygen consumption, and cardiac
output also play key roles in race performance [2]. During racing, horses experience a metabolic stress intricately
linked with electrolytic loss and energy metabolism [3]. The energy consumption is mainly dependent on the production of
adenosine triphosphate (ATP) in muscle, which generates energy through three
mechanisms. The phosphocreatine-ATP system provides instant energy when performing
short and high-intensity exercises; the muscle glycolytic system involves anaerobic
production of ATP, and is limited when lactate concentration reaches its threshold
range; and the oxidative system provides more energy through oxidation of glucose,
fatty acids and, proteins [4]. To reveal the
role of metabolites in race performance, high-throughput techniques such as nuclear
magnetic resonance (NMR) spectroscopy and mass spectrometry are being used [5]. In recent years, NMR-based studies have been
used to quantify many metabolites in serum, plasma, urine, and tissues [6,7].Branched-chain amino acids (BCAAs), e.g., isoleucine, leucine, and valine, play
important roles in the skeletal muscle metabolism. These amino acids are essential
amino acids which activate protein synthesis after exercise. Supplementation with
BCAAs in combination with resistance exercise led to an increase in the
phosphorylation of p70 (S6k) in human skeletal muscle [8]. Leucine regulates signaling pathways involved in
translational control of protein synthesis in skeletal muscle [9]. Inhibition of AMP-activated protein by leucine stimulates
mammalian target of rapamycin (mTOR) signaling in C2C12 myoblasts [10]. The catabolism of BCAAs in skeletal muscle
is well studied in human and rats [11,12]. Two enzymes, namely the branched chain
(alpha) keto acid dehydrogenase complex (BCKDH) and branched chain (alpha) keto acid
dehydrogenase kinase complex (BCKDK), tightly regulate this pathway [12,13].
These enzymes are abundant in the inner mitochondrial membrane in various tissues.
The BCKDH multienzyme complex consists of three enzyme units namely E1
(α-ketoacid dehydrogenase), E2 (dihydrolipoyltransacylase), and E3
(dihydrolipoamide dehydrogenase). The E1 subunit consists of E1-α and
E1-β chains encoded by BCKDHA and BCKDHB
[14,15]. The catalytic activity of this enzyme is further regulated by the
BCKDK complex. This complex is encoded by BCKDK. Various mutations
and defects in BCKDHB and BCKDK are associated
with maple syrup urine disease and neurological defects in human [16,17].Various studies focused on BCCA concentrations in plasma or serum in the
post-exercise period have reported an increased concentration of BCCAs [18]. Most of the studies quantified metabolite
levels in endurance racehorses [19,20]. The effects of metabolites in the skeletal
muscle have not been studied well, which restricts the analysis of metabolites for
muscle physiology and energy metabolism. Moreover, studies evaluating differences
between breeds of horses at the metabolomic and gene expression levels have not been
reported to date, despite its importance in the analysis of racing performance in
horses. The purpose of this study was to compare the metabolite and gene expression
levels involved in energy production during the pre- and post-exercise period in two
breeds of horses.
MATERIALS AND METHODS
Sample collection
Two stallions and one mare Throughbred horses aged 5, 9, and 10, weighing from
500 to 700 kg which were maintained at Ham-an Racing Horse Resort and Training
Center were used to obtain the blood and skeletal muscle samples before and
after exercise. Exercise was performed by trotting at the speed of 13 km/h for
30 min and cantering through lunging and long-reining (circular bridge
lunging).Three Jeju horses (3 mares), which were maintained at The National Institute of
Subtropical Agriculture, Rural Development Administration were used to obtain
tissue samples skeletal muscle, kidney, thyroid, lung, appendix, colon, spinal
cord and heart. Venous blood samples were collected using a 20 mL syringe and
transferred to ethylenediaminetetraacetic acid (EDTA)-containing tubes. For the
skeletal muscle biopsy, local anesthesia was administered to the gluteus
medius in muscle, and a biopsy collection syringe was then used to
obtain the muscle samples. All samples were stored at –80°C before
RNA extraction. All procedures were conducted by following the protocol that had
been reviewed and approved by the Institutional Animal Care and Use Committee at
Pusan National University (protocol numbers: PNU-2013-0417, PNU-2013-0411,
PNU-2015-0864).
Equine muscle cell culture and in vitro stress-induced systems
The horse muscle-derived cells were established in our previous study [20]. The horse muscle cells were routinely
cultured in medium 199 (Gibco, Grand Island, NY, USA) supplemented with 10%
fetal bovine serum (Invitrogen, Waltham, MA, USA) and 1%
antibiotic–antimycotic (Invitrogen), and kept at 37°C and 5%
CO2 environment. Routine medium changes were performed three
times a week. Cells at 70% to 80% confluency were gently washed twice with
phosphate-buffered saline (PBS) and harvested using 0.05% trypsin-EDTA (Welgene,
Gyeongsan, Korea) for expansion.To induce various stresses, horse muscle cells at 70% to 80% confluency were
incubated with 20 µg/mL cortisol [21].
RNA extraction and complementary DNA synthesis
Horse muscle-derived cells from the initial culture were plated in a 6-well plate
and incubated for 24 h. They were then treated with 20 µg/mL cortisol and
incubated for 8 h then harvested. A mixture made of lysis buffer and
2-mercaptoethanol (1 mL:10 µL) was added to the harvested cells, followed
by an equivalent volume of 70% ethanol, and the mixture was vortexed thoroughly
to ensure complete cell lysis. The mixture was then transferred to the spin
cartridge with a collection tube and centrifuged at 12,000×g for 15 s at
room temperature. After centrifugation, the flow-through was discarded and the
spin cartridge was reinserted into the same collection tube. Then, 700 µL
of wash buffer I was added, and the mixture was centrifuged at 12,000×g
for 1 min at room temperature. The flow-through was discarded and the spin
cartridge was inserted into a new collection tube. After, 500 µL of wash
buffer II was added and the mixture was centrifuged at 12,000×g for 1
min. The flow-through was discarded and the spin cartridge reinserted into the
same collection tube. This process was repeated and additionally centrifuged at
13,000×g for 1 min to dry the membrane with bound RNA. After, the
flow-through was discarded and the spin cartridge inserted into a recovery tube
of 1.5 mL. Thirty µL of RNase-free water was added to the center of the
spin cartridge and incubated for 1 to 5 min and then centrifuged at
12,000×g for 1 min to elute the RNA from the membrane into the recovery
tube. RNA quantity was determined using a spectrophotometer. RNA measurements
obtained were then used to calculate the volume of RNA, H2O, 5xBF,
dNTP, RNAse inhibitor, OligodT, and RTase needed for cDNA synthesis, and the
mixture was subject to reverse transcription.
To quantitate the gene expression levels of BCKDK in muscle
tissues and blood cells before and after exercise, a quantitative reverse
transcription polymerase chain reaction (qRT-PCR) was conducted using the BioRad
CFX-96 apparatus (BioRad, Hercules, CA, USA). Each reaction was conducted in a
25 μL mixture containing 14 μL of SYBR Green Master Mix, 2
μL of forward primer (5 pmol), 2 μL of reverse primer (5 pmol), 5
μL of distilled water, and 2 μL (50 ng/μL) of cDNA. PCR
conditions were as follows: a predenaturation step at 94°C for 5 min; 39
cycles at 94°C for 20 s, 56°C for 20 s, and 72°C for 30 s;
and a final step at 72°C for 10 min. All measurements were performed in
triplicate for all specimens, and the 2−ΔΔCt
method was to compare the data [22]. The
relative expression level of each target gene was calculated by normalizing the
expression level against that of glyceraldehyde-3-phosphate dehydrogenase.
Statistical analysis
Student’s t-test and analysis of variance were conducted
to determine significance levels. Data were shown as the mean ± SE.
RESULTS
Comparison of metabolites between Thoroughbred and Jeju horses
In our previous study, differentially present metabolites were identified in
Thoroughbreds [23]. In this study, we
identified differentially present metabolites in Jeju horses, and conducted a
comparison analysis between Thoroughbred and Jeju horses. We obtained massive
metabolomic data from equine plasma (Table
1) and muscle (Table 2). Among
the massive metabolites, we obtained each of the four metabolites, which were
present at different levels in both the plasma (Table 3) and muscle (Table
3). Alanine, methionine, and taurine were significantly expressed in the
plasma sample before exercise, while lysine was significantly expressed after
exercise. In muscle samples, aspartate, isoleucine, leucine, and lysine were
significantly expressed before exercise, whereas none were significantly
expressed after exercise. In addition, we analyzed the levels of metabolites in
Thoroughbred and Jeju horses. Jeju horses had a significantly lower level of
alanine, lysine, and methionine; and a higher level of taurine in plasma
(p < 0.05) than in Thoroughbred horses (Fig. 1). On the other hand, no other
metabolites were found to be either significantly low or high in plasma. No
significant differences were found between the amino acids and other metabolites
after exercise, except for lysine. When compared to Jeju horses, Thoroughbred
horses had a significantly higher level of lysine (p <
0.05), (Table 1). The metabolite profile
of skeletal muscles in both breeds indicate very few differences at the region
of BCCAs and lysine (Table 2). In muscles
during the pre-exercise period, Jeju horses had a significantly higher level of
aspartate, isoleucine, leucine, and lysine than in Thoroughbred horses
(p < 0.05) (Fig.
2). Other metabolites related to exercise did not have a significant
difference in skeletal muscle. Thoroughbred horses had a significantly higher
level of phospholipid derivative o-phosphocholine than in Jeju horses
(p value: <0.05), and no other significant
differences were seen for metabolites in muscle (Table 2).
Table 1.
Comparison of metabolites composition between Thoroughbred and Jeju
horses in plasma
Metabolites
Before ppm
After ppm
TH
JH
p-value
TH
JH
p-value
Acetate
5.36 ± 6.88
0.48 ± 0.18
0.29
4.96 ± 7.57
1.29 ± 1.07
0.45
Alanine
7.34 ± 0.42
5.40 ± 0.94
0.03*
5.40 ± 2.22
5.53 ± 1.60
0.94
Choline
1.77 ± 2.06
0.45 ± 0.30
0.33
0.38 ± 0.31
0.52 ± 0.18
0.55
Creatine
1.21 ± 0.55
1.32 ± 0.65
0.83
1.19 ± 0.49
1.14 ± 0.62
0.92
Glutamate
0.92 ± 0.13
2.01 ± 0.93
0.12
1.81 ± 1.06
1.99 ±0.54
0.81
Glutamine
0.57 ± 0.09
0.72 ± 0.34
0.50
0.69 ± 0.25
0.92 ± 0.69
0.62
Glycine
7.73 ± 0.84
5.88 ± 1.83
0.19
8.33 ± 3.68
6.32 ± 1.77
0.44
Histidine
1.22 ± 0.49
1.17 ± 0.19
0.87
1.58 ± 0.54
1.04 ± 0.14
0.17
Isoleucine
1.09 ± 0.20
0.76 ± 0.44
0.31
0.83 ± 0.33
0.60 ± 0.41
0.50
Lactate
47.10 ± 9.83
46.96 ±15.33
0.99
37.38 ± 11.59
44.95 ± 11.49
0.47
Leucine
1.81 ± 0.22
1.11 ± 0.38
0.05
2.07 ± 0.40
1.48 ± 0.49
0.18
Lysine
1.30 ± 0.46
0.78 ± 0.26
0.16
1.54 ± 0.26
0.70 ± 0.13
0.008*
Methionine
0.38 ± 0.04
0.21 ± 0.08
0.03*
0.23 ± 0.09
0.26 ± 0.14
0.81
Myo-Inositol
0.25 ± 0.16
0.34 ± 0.09
0.45
0.36 ± 0.08
0.52 ± 0.37
0.49
Phenylalanine
0.29 ± 0.16
0.25 ± 0.09
0.69
0.22 ± 0.09
0.37 ± 0.09
0.11
Proline
1.29 ± 0.36
1.33 ± 0.81
0.95
1.40 ± 0.40
1.10 ± 0.87
0.61
Pyruvate
12.38 ± 14.39
21.24 ± 6.50
0.39
18.25 ± 17.79
22.16 ± 6.41
0.74
Taurine
0.66 ± 0.41
2.01 ± 0.13
0.01*
0.99 ± 0.55
1.67 ± 0.49
0.18
Threonine
0.65 ± 0.28
1.36 ± 0.50
0.10
0.78 ± 0.17
1.16 ± 0.38
0.19
Tyrosine
0.49 ± 0.13
0.34 ± 0.08
0.17
0.30 ± 0.13
0.47 ± 0.20
0.26
Valine
3.24 ± 0.26
2.87 ± 1.26
0.65
2.74 ± 0.74
2.80 ± 1.13
0.94
All values expressed in ppm as mean ± SD.
p < 0.05.
TH, Thoroughbred horse; JH, Jeju horse.
Table 2.
Comparison of metabolites composition between Thoroughbred and Jeju
horses in skeletal muscle
Metabolites
Before ppm
After ppm
TH
JH
p-value
TH
JH
p-value
Acetate
0.18 ± 0.04
0.47± 0.24
0.11
0.30 ± 0.11
0.18 ± 0.03
0.13
Alanine
1.02 ± 0.43
1.01 ± 0.31
0.97
1.41 ± 0.48
0.93 ± 0.20
0.18
Anserine
0.30 ± 0.02
0.29 ± 0.14
0.96
0.50 ± 0.14
0.34 ± 0.13
0.22
Arginine
0.57 ± 0.09
1.07 ± 0.29
0.05
0.52 ± 0.18
0.42 ± 0.25
0.60
Aspartate
0.71 ± 0.28
1.62 ± 0.43
0.04*
0.84 ± 0.84
1.03 ± 0.42
0.75
Betaine
0.44 ± 0.15
0.28 ± 0.18
0.32
0.27 ± 0.12
0.28 ± 0.21
0.95
Carnitine
1.79 ± 1.38
1.30 ± 0.45
0.59
1.55 ± 0.43
1.32 ± 0.26
0.48
Choline
0.54 ± 0.22
0.25 ± 0.08
0.10
0.44 ± 0.29
0.28 ± 0.17
0.47
Creatine
29.22 ± 5.79
28.24 ± 3.02
0.81
29.28 ± 8.23
34.47 ± 4.47
0.39
Cysteine
1.72 ± 0.27
2.20 ± 0.47
0.20
1.21 ± 0.40
0.57 ± 0.51
0.17
Fumarate
0.11 ± 0.04
0.10 ± 0.02
0.65
0.11 ± 0.06
0.09 ± 0.01
0.39
Glucose
2.78 ± 0.52
2.95 ± 0.77
0.77
4.31 ± 1.60
3.70 ± 0.24
0.55
Glutamate
0.49 ± 0.17
0.81 ± 0.18
0.09
0.75 ± 0.52
0.56 ± 0.24
0.60
Glutamine
1.35 ± 0.64
1.47 ± 0.48
0.80
1.52 ± 0.27
1.43 ± 0.32
0.72
Glycine
0.82 ± 0.21
1.20 ± 0.60
0.36
1.18 ± 0.38
1.26 ± 0.36
0.81
Isoleucine
0.16 ± 0.03
0.41 ± 0.12
0.02*
0.29 ± 0.18
0.18 ± 0.07
0.39
Lactate
45.19 ±10.63
43.07 ± 6.67
0.78
42.12 ±6.85
42.45 ± 2.70
0.94
Leucine
0.35 ± 0.07
1.19 ± 0.23
0.01*
0.62 ± 0.37
0.43 ± 0.14
0.45
Lysine
0.19 ± 0.05
0.62 ± 0.22
0.03*
0.24 ± 0.10
0.22 ± 0.11
0.84
Methionine
0.75 ± 0.09
1.23 ± 0.61
0.25
0.70 ± 0.07
1.03 ± 0.47
0.30
Myo-inositol
0.57 ± 0.21
0.58 ± 0.16
0.97
0.65 ± 0.14
0.52 ± 0.10
0.25
O- Phosphocholine
0.47 ± 0.14
0.35 ± 0.07
0.27
0.61 ± 0.15
0.28 ± 0.08
0.03*
O- Phosphoethanolamine
1.32 ± 0.68
0.94 ± 0.62
0.52
1.36 ± 0.48
0.40 ± 0.34
0.05
Phenylalanine
0.19 ± 0.16
0.17 ± 0.03
0.80
0.18 ± 0.06
0.11 ± 0.06
0.24
Proline
1.30 ± 0.74
1.15 ± 0.33
0.77
0.92 ± 0.28
0.92 ±0.32
0.98
Pyruvate
0.22 ± 0.30
0.50 ± 0.38
0.38
0.43 ± 0.33
0.34 ± 0.09
0.67
Serine
1.19 ± 0.29
1.26 ± 0.62
0.87
1.35 ± 0.18
0.70 ± 0.65
0.17
sn-Glycerol-3-phosphate
0.62 ± 0.11
0.49 ± 0.10
0.22
0.67 ± 0.30
0.46 ± 0.21
0.21
Succinate
0.06 ± 0.02
0.05 ± 0.01
0.34
0.63 ± 1.03
0.06 ± 0.01
0.39
Taurine
3.56 ± 1.21
2.97 ± 1.16
0.57
3.12 ± 0.65
3.48 ± 1.79
0.76
Threonine
0.69 ± 0.12
0.43 ± 0.16
0.08
0.50 ± 0.34
0.41 ± 0.12
0.67
Tyrosine
0.15 ± 0.04
0.19 ± 0.04
0.30
0.21 ± 0.03
0.16 ± 0.02
0.07
Valine
0.28 ± 0.06
0.39 ± 0.12
0.22
0.52 ± 0.18
0.25 ± 0.05
0.07
All values expressed in ppm as mean ± SD.
p < 0.05.
TH, Thoroughbred Horse; JH, Jeju Horse.
Table 3.
Comparison of metabolites in plasma and muscle in Thoroughbred horses
(TH) and Jeju horses (JH)
S.No.
Metabolites
Before (Mean
±SD)
After (Mean
±SD)
TH
JH
p-value
TH
JH
p-value
Plasma
1.
Alanine
7.34 ± 0.42
5.40 ± 0.94
0.03*
5.40 ± 2.22
5.53 ± 1.60
0.94
2.
Lysine
1.30 ± 0.46
0.78 ± 0.26
0.16
1.54 ± 0.26
0.70 ± 0.13
0.008*
3.
Methionine
0.38 ± 0.04
0.21 ± 0.08
0.03*
0.23 ± 0.09
0.26 ± 0.14
0.81
4.
Taurine
0.66 ± 0.41
2.01 ± 0.13
0.01*
0.99 ± 0.55
1.67 ± 0.49
0.18
Muscle
1.
Aspartate
0.71 ± 0.28
1.62 ± 0.43
0.04*
0.84 ± 0.84
1.03 ± 0.42
0.75
2.
Isoleucine
0.16 ± 0.03
0.41 ± 0.12
0.02*
0.29 ± 0.18
0.18 ± 0.07
0.39
3.
Leucine
0.35 ± 0.07
1.19 ± 0.23
0.01*
0.62 ± 0.37
0.43 ± 0.14
0.45
4.
Lysine
0.19 ± 0.05
0.62 ± 0.22
0.03*
0.24 ± 0.10
0.22 ± 0.11
0.84
5.
O-Phosphocholine
0.47 ± 0.14
0.35 ± 0.07
0.27
0.61 ± 0.15
0.28 ± 0.08
0.03*
p < 0.05.
Fig. 1.
Significant differences in plasma metabolite levels between
Thoroughbred and Jeju horses (A) alanine (before exercise), (B) lysine
(after exercise), (C) methionine (before exercise) and (D) taurine
(before exercise).
*p < 0.05. All values are expressed in ppm as the
mean ± SD. TH, Thoroughbred horse; JH, Jeju horse.
Fig. 2.
Significant differences in skeletal muscle metabolite levels between
Thoroughbred and Jeju horses (A) leucine (before exercise), (B)
isoleucine (before exercise), (C) lysine (before exercise), (D)
aspartate (before exercise) and o-phosphocholine (after
exercise).
*p < 0.05. All values are expressed in ppm as the
mean ± SD. TH, Thoroughbred horse; JH, Jeju horse.
All values expressed in ppm as mean ± SD.p < 0.05.TH, Thoroughbred horse; JH, Jeju horse.All values expressed in ppm as mean ± SD.p < 0.05.TH, Thoroughbred Horse; JH, Jeju Horse.p < 0.05.
Significant differences in plasma metabolite levels between
Thoroughbred and Jeju horses (A) alanine (before exercise), (B) lysine
(after exercise), (C) methionine (before exercise) and (D) taurine
(before exercise).
*p < 0.05. All values are expressed in ppm as the
mean ± SD. TH, Thoroughbred horse; JH, Jeju horse.
Significant differences in skeletal muscle metabolite levels between
Thoroughbred and Jeju horses (A) leucine (before exercise), (B)
isoleucine (before exercise), (C) lysine (before exercise), (D)
aspartate (before exercise) and o-phosphocholine (after
exercise).
*p < 0.05. All values are expressed in ppm as the
mean ± SD. TH, Thoroughbred horse; JH, Jeju horse.
Functional analysis and evolutionary analysis of BCKDK as branched-chain
amino acid related genes (DEGs)
Based on metabolomic data, we found isoleucine and leucine, which are BCAAs
significantly expressed in Jeju and Thoroughbred horses. As mentioned, the BCKDH
and BCKDK are tightly involved in the BCAA signaling pathway. Therefore, we
evaluated BCKDK expression in the muscle tissue of Jeju and
Thoroughbred horses.Equine BCKDK is located in chromosome 13, and the genomic
structure is shown in Fig. 3. The BCKDK
gene consists of 11 exons, and the full lengths is 1,239 bp. Equine
BCKDK encodes 412 amino acids. To investigate the
evolutionary relationships of BCKDK in horses, we extracted and compared amino
acid sequences from eight species (frog, mouse, rat, cow, horse, wild horse,
dog, human) from Ensembl 62, and conducted a phylogenetic analysis (Fig. 3B). Multiple alignment using the
‘histidine kinase-like ATPases’ domain showed higher identity
(Fig. 3C, solid box). Therefore, we
suggest that BCKDK is highly conserved between various species and these domains
would have an important role in the exercise stress response.
Fig. 3.
Analysis of amino acid sequences and phylogenetic tree of branched
chain (alpha) keto acid dehydrogenase kinase complex (BCKDK) gene among
various species.
(A) Gene structure of the branched chain (alpha) keto acid dehydrogenase
kinase complex (BCKDK) gene in horses. Black boxes indicate exons, grey
boxes indicate untranslated regions (UTR), and black lines indicate
introns. (B) Phylogenetic tree of BCKDK. The phylogenetic tree was made
with the full amino acid sequences of each species by Neighbor-Joining
method after alignment by the MUSCLE method using GENEIOUS. Horse AXL
was more similar to cow and dog than to frog and mouse. (C)
‘Alignments of histidine kinase-like ATPases’ domain of
BCKDK from various species. The sequences were aligned by the MUSCLE
method in GENEIOUS program.
Analysis of amino acid sequences and phylogenetic tree of branched
chain (alpha) keto acid dehydrogenase kinase complex (BCKDK) gene among
various species.
(A) Gene structure of the branched chain (alpha) keto acid dehydrogenase
kinase complex (BCKDK) gene in horses. Black boxes indicate exons, grey
boxes indicate untranslated regions (UTR), and black lines indicate
introns. (B) Phylogenetic tree of BCKDK. The phylogenetic tree was made
with the full amino acid sequences of each species by Neighbor-Joining
method after alignment by the MUSCLE method using GENEIOUS. Horse AXL
was more similar to cow and dog than to frog and mouse. (C)
‘Alignments of histidine kinase-like ATPases’ domain of
BCKDK from various species. The sequences were aligned by the MUSCLE
method in GENEIOUS program.
Validation of BCKDK expression in equine muscle tissue and horse
muscle-derived cells under stress
To validate BCKDK gene expression, which we deduced from metabolomic data as a
differentially expressed metabolite related gene, we conducted qRT-PCR with
Thoroughbred and Jeju horse muscle tissue (Fig.
4). The expression level of BCKDK significantly
decreased after exercise in both horse breeds, even though the expression level
in Thoroughbred horses decreased more than that of Jeju horses. Additionally, we
investigated the expression patterns of BCKDK in horse
muscle-derived cells under stress. To validate BCKDK expression
under stress, we conducted qRT-PCR on cortisol treated horse muscle-derived
cells. In a previous study, we established a cortisol treatment system [21]. In this study, quantitative expression
analysis was performed on BCKDK by cortisol reactivity (Fig. 5). To verify the effect of cortisol on
stress induction, expression patterns of stress marker genes were investigated
(Fig. 5B). We found that the expression
levels of the marker genes of stress increased substantially. Next, we examined
the effects of cortisol on the horse muscle-derived cells.
BCKDK expression level increased after cortisol treatment
(p < 0.01, Fig.
5C). In addition, we investigated the effect of methyl sulfonyl
methane (MSM) on stress reduction (p < 0.01, Fig. 5D). We found that MSM did not reduce
stress by regulating BCKDK. It is assumed that MSM may reduce
exercise stress through another signaling pathway.
Fig. 4.
BCKDK gene expression in skeletal muscle of Thoroughbred and Jeju
horses.
(A) BCKDK in Thoroughbred horses. (B) BCKDK in Jeju horses. BCKDK gene
expression significantly decreased after the exercise in Thoroughbred
horses (n = 3, *p < 0.05, **p
< 0.01, ***p < 0.001,
****p < 0.0001. Error bars indicate standard
error). The relative expression for each gene was normalized to that of
GAPDH and calculated with the 2−rr CT method (mean ± SD of
triplicate experiments; two-tailed Student t-test).
BCKDK, branched chain (alpha) keto acid dehydrogenase kinase
complex.
Fig. 5.
Effects of exercise stress on BCKDK gene expression in horse
muscle-derived cells and effects of methylsulfonylmethane (MSM) on
stress reduction.
(A) Morphology of horse muscle-derived cells. (B) ATF4 gene, as exercise
stress marker gene expression using qRT-PCR. white and grey bars
represent gene expression in the presence and absence of cortisol
treatment (30 ug/mL). (C) Expression of horse BCKDK analyzed using
RT-PCR in horse muscle-derived cells after treatment with 30
μg/mL cortisol. Data are presented as one of three independent
experiments. (D) Analysis of relative BCKDK gene expression using
qRT-PCR under cortisol and MSM treatment. white and grey bars represent
gene expression in the presence and absence of MSM treatment (100 mM),
under exercise stress (30 μg/mL cortisol). The relative
expression for each gene was normalized to that of GAPDH and calculated
with the 2−△△ CT method (mean ±
SD of triplicate experiments; two-tailed Student
t-test). BCKDK, branched chain (alpha) keto acid
dehydrogenase kinase complex; qRT-PCR, quantitative real-time polymerase
chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
BCKDK gene expression in skeletal muscle of Thoroughbred and Jeju
horses.
(A) BCKDK in Thoroughbred horses. (B) BCKDK in Jeju horses. BCKDK gene
expression significantly decreased after the exercise in Thoroughbred
horses (n = 3, *p < 0.05, **p
< 0.01, ***p < 0.001,
****p < 0.0001. Error bars indicate standard
error). The relative expression for each gene was normalized to that of
GAPDH and calculated with the 2−rr CT method (mean ± SD of
triplicate experiments; two-tailed Student t-test).
BCKDK, branched chain (alpha) keto acid dehydrogenase kinase
complex.
Effects of exercise stress on BCKDK gene expression in horse
muscle-derived cells and effects of methylsulfonylmethane (MSM) on
stress reduction.
(A) Morphology of horse muscle-derived cells. (B) ATF4 gene, as exercise
stress marker gene expression using qRT-PCR. white and grey bars
represent gene expression in the presence and absence of cortisol
treatment (30 ug/mL). (C) Expression of horse BCKDK analyzed using
RT-PCR in horse muscle-derived cells after treatment with 30
μg/mL cortisol. Data are presented as one of three independent
experiments. (D) Analysis of relative BCKDK gene expression using
qRT-PCR under cortisol and MSM treatment. white and grey bars represent
gene expression in the presence and absence of MSM treatment (100 mM),
under exercise stress (30 μg/mL cortisol). The relative
expression for each gene was normalized to that of GAPDH and calculated
with the 2−△△ CT method (mean ±
SD of triplicate experiments; two-tailed Student
t-test). BCKDK, branched chain (alpha) keto acid
dehydrogenase kinase complex; qRT-PCR, quantitative real-time polymerase
chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
DISCUSSION
Comparison studies in horses showed that there are variations between amino acid
concentrations in skeletal muscle [24]. Among
these amino acids, isoleucine and leucine, which are BCAAs, play pivotal roles in
exercise physiology [25]. Additionally, the
basic amino acid lysine also plays important roles in skeletal muscle metabolism
[26]. The comparison analysis shows the
physiological status of Thoroughbreds and Jeju horses. Elevated amounts of alanine,
methionine, and taurine in plasma pre-exercise in Thoroughbreds, suggest their
capacity to perform in races. In skeletal muscle, high amounts of aspartate,
isoleucine, leucine, and lysine in Jeju horses indicate their slow ability to
respond to exercise. This finding is supported by the low amount of phosphocholine
in Jeju horses. In general, alterations in the concentrations of essential amino
acids such as methionine, isoleucine, leucine, and lysine in plasma and /or in
skeletal muscle reflects the important functions of essential amino acids in
moderate exercise. Moreover, various studies on horses showed decreased BCCAs in
plasma and changes in skeletal muscle [27].
Generally, exercise induces protein degradation in skeletal muscle, but several
studies on humans and horses showed that supplementation of amino acids reduces this
process [28]. Furthermore, Thoroughbred
horses participate in daily racing practice; this may contribute to the lesser
amounts of these amino acids in their skeletal muscle. Thoroughbred horses have been
specially bred for sports; and the racing ability of this breed is higher than in
Jeju horses [29]. Physiological factors such
as body weight and height contribute to racing ability. In contrast to
Thoroughbreds, Jeju horses have low weight and height which has been used for
mechanical work. A decreased expression level of BCKDK after
exercise in Thoroughbred horses indicates their catabolic ability to BCAAs. As a
result, low levels of BCKDK enzymes available in skeletal muscle could activate the
BCKDH enzyme complex while performing exercise. Despite these results, we propose
that low levels of BCKDK in Thoroughbred horses leads to the activation of the BCKDH
enzyme complex, and as a result the catabolism of BCAAs is increased in skeletal
muscle. These consequent reactions may lead to BCCAs acting as fuels, as well as
anabolic signals for protein synthesis in Thoroughbred horses. For Jeju horses, the
lack of change in BCKDK gene expression level may lead to continued suppression of
the BCKDH complex, which would result in high levels of BCAAs in skeletal muscle.
Moreover, binding of the BCKDH complex with BCKDK also plays an important role in
this catabolic process. The process has been well studied in rats, and the results
have shown that BCKDK capacity to bind to the BCKDH complex crucially affects BCKDH
catalytic activity [30]. In this study, we
focused on metabolomes and transcriptomes, but not proteomes. Collectively, the
results presented indicate that BCKDK genes play important roles in the exercise
response.
Authors: Olaf Beckonert; Hector C Keun; Timothy M D Ebbels; Jacob Bundy; Elaine Holmes; John C Lindon; Jeremy K Nicholson Journal: Nat Protoc Date: 2007 Impact factor: 13.491